A survey of the world’s top universities placed the University of Wisconsin–Madison as the seventh-greatest source of U.S. patents. The ranking, by the National Academy of Inventors and Intellectual Property Owners Association, attests to UW–Madison’s continued success in the granting of “utility” patents for inventions...
A Madison-Milwaukee scientific partnership is powering an effort to better understand the complicated mechanics of human vision. Melissa Skala, a Morgridge Institute for Research investigator and UW-Madison professor of biomedical engineering, develops applications in photonics-based imaging that offer many research benefits, most notably that they do...
Dan Malven isn’t a wide-eyed optimist by nature. He’s a sober, even cautious, venture capitalist who is diligent about investments made by the fund he helps manage, Wisconsin-based 4490 Ventures. When it comes to how he views the investment climate in the Midwest, however, Malven is...
Early data on pancreatic cancer detection presented at Digestive Disease Week® 2019 SAN DIEGO, CA – May 20, 2019 – Early research using blood-based methylated DNA markers, identified through the longstanding collaboration between Exact Sciences and Mayo Clinic, demonstrates a potential to achieve 92% sensitivity and 92% specificity...
A new drug discovery and development company is taking root in Madison, and it will prevent more than a dozen skilled scientists here from losing their jobs. Nimble Therapeutics formed in April, spun out of Roche Sequencing Solutions, originally NimbleGen Systems, which is slated to close by...
To Bill Murphy and the other leaders of the Forward BIO Initiative, Wisconsin possesses all the elements to become a hub of biomanufacturing in the United States, the Midwest’s version of Boston or San Francisco in this rapidly expanding industry. “Our established, statewide excellence in research, technology development and...
Cardiovascular disease is a major cause of death worldwide, and treating it isn’t easy. The disease wreaks havoc on patients’ blood vessels and can require complex bypass surgery. Scientists at the Morgridge Institute for Research are working toward a dream of creating artery banks — similar...
Could a blood cell type responsible for scarring and diseases such as pulmonary fibrosis be repurposed to help engineer healthy tissue? A new study by a University of Wisconsin School of Medicine and Public Health researcher shows that someday, fibrocytes may be used for regenerative therapies...
By Aaron Olver- May 7, 2019 Olver is managing director of University Research Park in Madison and a member of the board of directors for the Wisconsin Technology Council, which is headquartered in URP. By this time in 2020, University Research Park’s footprint, the portfolio of labs and...
NeuroPointDX presents further data from the Children’s Autism Metabolome Project at INSAR 2019 MADISON, WI (May 6, 2019): Continued analysis of samples from the Children’s Autism Metabolome Project (CAMP), the most comprehensive clinical study of metabolism in children who has autism spectrum disorder (ASD) conducted to date,...